The effect of sodium-glucose cotransporter 2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes mellitus on cardiovascular and renal outcomes: A systematic review and meta-analysis

BACKGROUND: Sodium-glucose cotransporter 2 (SGLT-2) inhibitors have shown a favorable effect on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus (T2DM). However, their efficacy in patients with chronic kidney disease (CKD) with or without T2DM has not yet been analyzed. OB...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes-Farias, Carlos Ignacio, Reategui-Diaz, Marcelo, Romani-Romani, Franco, Prokop, Larry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686459/
https://www.ncbi.nlm.nih.gov/pubmed/38019892
http://dx.doi.org/10.1371/journal.pone.0295059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686459/
https://www.ncbi.nlm.nih.gov/pubmed/38019892
http://dx.doi.org/10.1371/journal.pone.0295059

Ejemplares similares